Home / Intelligence / Case Studies / Dynamic Targeting Solution
Client Situation
A large biopharma customer wanted to develop a dynamic targeting solution for HCPs in a particular market
Trinity’s Role
- Using machine learning, Trinity developed a model to predict HCPs’ future prescribing engagement
- Segmented prescribers into targeting tiers, updated on a quarterly basis
- Prioritized the prescriber tiers
Project Outcomes
- Trinity delivered a model with 84% accuracy.*
- The solution supports a new, agile approach to call planning and execution to achieve better engagement using advanced analytics to dynamically target HCPs based on their needs, their patient’s needs and their preferences.
*Based on model F1-score
Related Intelligence
Webinars
Unlocking Medical Impact with AI
September 18, 2025 | 1:00 – 1:45 PM ET
Medical Affairs teams are under growing pressure to deliver faster insights, smarter engagement, and measurable value—yet many are limited by manual processes, fragmented data, and time-intensive workflows. Join us for the next webinar in our “AI Innovations in Life Sciences” series, where Trinity experts will show how it is possible with AI to unlock deeper, novel insights, power efficient workflows, and drive greater impact in the Medical Affairs field and headquarters functions.
Sign Up Now
Blog
Trinity Life Sciences Unveils Groundbreaking Trinity Digital Affinity, Powered by DeepIntent, to Transform HCP Engagement for Life Sciences
In today’s fast-evolving digital landscape, life sciences companies face a critical challenge: reach the right healthcare professionals (HCPs) with the right message, through the right channels, at the right time. At Trinity Life Sciences, we’re proud to help our clients meet that challenge head-on with the launch of Trinity Digital Affinity, powered by DeepIntent. This […]
Read More
Analyst Reports
Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence
Trinity Life Sciences is a Leader in Everest Group’s 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment—with its distinction rooted in exceptional, tangible outcomes delivered for clients across the life sciences sector.
Read More